Note sull'episodio
This week on the podcast, we have conversations about hiring in the lifesciences industry in 2025, and about a potential new class of synthetic therapeutics.
Interview times:
02:49 ThirdLaw Molecular
21:14 Occam Global
ThirdLaw Molecular
ThirdLaw Molecular is a biotech company that has pioneered the discovery and development of Spiroligomer molecules – a groundbreaking new platform for targeted drug discovery.
The company is designing and synthesizing libraries of billions of Spiroligomer-based molecules and is entering into research collaborations with pharmaceutical organizations to identify and optimize highly targeted drug-development candidates.
ThirdLaw ...
Parole chiave
biotechbiotechnologyThirdLaw MolecularOccam GlobalSpiroligomershiring